Heptares and AstraZeneca: Combining forces in novel approach to drug discovery

Heptares Therapeutics is a pioneer in G protein-coupled receptors structure-based drug design. By combining their expertise and technologies with AstraZeneca’s drug discovery capabilities, we hope to open up new treatment options for people suffering from pain of osteoarthritis, from inflammatory diseases or cancer.